Get In Touch With Us
Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
35 Nixon Road, Unit 1
Bolton, ON L7E 1K1
Canada
Ken d’Entremont
Chief Executive Officer and Director
ken.dentremont@medexus.com
905-676-0800
Marcel Konrad
Chief Financial Officer
marcel.konrad@medexus.com
312-548-3139
Business Development or Partnering Inquiries
Michael Pine
SVP Business Development & Strategy
michael.pine@medexus.com
Investor Relations (US)
Crescendo Communications, LLC
David Waldman / Natalya Rudman
mdp@crescendo-ir.com
212-671-1020
Investor Relations (Canada)
Tina Byers
Adelaide Capital
Tel: 905-330-3275
E-mail: tina@adcap.ca
Direct Financial Strategies and Communication Inc.
Frank Candido
frank.candido@medexus.com
514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987 or by written at MedexusPV@innomar-strategies.com.